Cholangio Cancer Therapy
Study results from Chiang Mai University, Department of Medicine provide new insights into cholangio cancer therapy
Published in Gastroenterology Week, July 30th, 2007
Researchers detail in "Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma," new data in cholangio cancer. In this recently published article, scientists in Chiang Mai, Thailand conducted a study "To study the activity of gemcitabine and cisplatin in a cohort of patients with inoperable or metastatic cholangiocarcinoma. Chemotherapy-naive patients with pathologically proven cholangiocarcinoma, receiving treatment that consisted of gemcitabine at 1250 mg/m2 in a 30-min infusion on d 1 and 8, and cisplatin at 75 mg/m2 at every 21-d cycle, were retrospectively analyzed."
"From June 2003 to December...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Allergies
Food for Thought -- Understanding Food Allergies in Kids - Colon Cancer
Sequential and combination chemotherapy equally effective in treating advanced colorectal cancer - Drug Resistance
Certain type of colitis now more common, severe among hospitalized patients - Esophageal Cancer
Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer - Obesity and Diabetes
Overweight Children: An Emerging Epidemic - Orthopedics
Sports hernia repair surgery plus innovative rehab program helps athletes return to play - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
